WallStSmart

Gemini Space Station, Inc. Class A Common Stock (GEMI)vsNomura Holdings Inc ADR (NMR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Nomura Holdings Inc ADR generates 1114279% more annual revenue ($2.17T vs $194.52M). NMR leads profitability with a 16.7% profit margin vs -278.9%. NMR earns a higher WallStSmart Score of 70/100 (B-).

GEMI

Hold

38

out of 100

Grade: F

Growth: 8.0Profit: 2.0Value: 5.0Quality: 6.3
Piotroski: 4/9

NMR

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.5Value: 7.7Quality: 3.5
Piotroski: 4/9Altman Z: 0.53

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

GEMI3 strengths · Avg: 10.0/10
Price/BookValuation
1.1x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
42.3%10/10

Revenue surging 42.3% year-over-year

Debt/EquityHealth
0.0410/10

Conservative balance sheet, low leverage

NMR4 strengths · Avg: 9.0/10
P/E RatioValuation
11.8x10/10

Attractively priced relative to earnings

Price/BookValuation
1.0x10/10

Reasonable price relative to book value

PEG RatioValuation
0.828/10

Growing faster than its price suggests

Revenue GrowthGrowth
27.5%8/10

Revenue surging 27.5% year-over-year

Areas to Watch

GEMI4 concerns · Avg: 2.8/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$594.23M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-120.7%2/10

ROE of -120.7% — below average capital efficiency

Free Cash FlowQuality
$-54.56M2/10

Negative free cash flow — burning cash

NMR4 concerns · Avg: 2.3/10
EPS GrowthGrowth
4.5%4/10

4.5% earnings growth

Free Cash FlowQuality
$-1.20T2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.532/10

Distress zone — elevated risk

Debt/EquityHealth
4.671/10

Elevated debt levels

Comparative Analysis Report

WallStSmart Research

Bull Case : GEMI

The strongest argument for GEMI centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 42.3% demonstrates continued momentum.

Bull Case : NMR

The strongest argument for NMR centers on P/E Ratio, Price/Book, PEG Ratio. Profitability is solid with margins at 16.7% and operating margin at 18.7%. Revenue growth of 27.5% demonstrates continued momentum.

Bear Case : GEMI

The primary concerns for GEMI are EPS Growth, Market Cap, Return on Equity.

Bear Case : NMR

The primary concerns for NMR are EPS Growth, Free Cash Flow, Altman Z-Score. Debt-to-equity of 4.67 is elevated, increasing financial risk.

Key Dynamics to Monitor

GEMI profiles as a hypergrowth stock while NMR is a growth play — different risk/reward profiles.

GEMI is growing revenue faster at 42.3% — sustainability is the question.

GEMI generates stronger free cash flow (-55M), providing more financial flexibility.

Monitor CAPITAL MARKETS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMR scores higher overall (70/100 vs 38/100), backed by strong 16.7% margins and 27.5% revenue growth. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Gemini Space Station, Inc. Class A Common Stock

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Gemini Space Station, Inc. develops a crypto platform to buy, sell, and store crypto assets. The company is headquartered in New York, New York.

Visit Website →

Nomura Holdings Inc ADR

FINANCIAL SERVICES · CAPITAL MARKETS · USA

Nomura Holdings, Inc. provides various financial services to individuals, corporations, financial institutions, governments, and government agencies worldwide. The company is headquartered in Tokyo, Japan.

Want to dig deeper into these stocks?